Eris Lifesciences Limited (NSE:ERIS)
India · Delayed Price · Currency is INR 1,378.40
-20.60 (-1.47%)
Jun 1, 2026, 3:29 PM IST
Eris Lifesciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 1, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 191,001 | 179,718 | 192,990 | 114,719 | 77,801 | 93,615 | |
Market Cap Growth | -3.67% | -6.88% | 68.23% | 47.45% | -16.89% | 13.96% |
Enterprise Value | 213,844 | 206,982 | 221,970 | 121,268 | 80,085 | 92,600 |
Last Close Price | 1378.40 | 1290.28 | 1409.78 | 834.11 | 565.83 | 673.97 |
PE Ratio | 30.46 | 29.01 | 54.85 | 29.26 | 20.36 | 23.05 |
Forward PE | 28.55 | 27.62 | 38.80 | 25.79 | 17.15 | 21.23 |
PS Ratio | 6.13 | 5.77 | 6.70 | 5.76 | 4.68 | 7.06 |
PB Ratio | 4.90 | 4.61 | 5.90 | 3.56 | 3.50 | 4.91 |
P/TBV Ratio | - | - | - | - | - | 8.10 |
P/FCF Ratio | 79.21 | 74.53 | 21.21 | 32.15 | - | 36.39 |
P/OCF Ratio | 35.50 | 33.41 | 18.12 | 23.60 | 26.67 | 24.75 |
PEG Ratio | 0.97 | 0.91 | 1.29 | 1.61 | 1.91 | 1.46 |
EV/Sales Ratio | 6.87 | 6.65 | 7.71 | 6.09 | 4.82 | 6.98 |
EV/EBITDA Ratio | 19.09 | 18.48 | 22.09 | 18.30 | 15.23 | 19.18 |
EV/EBIT Ratio | 25.44 | 24.62 | 31.59 | 24.53 | 18.99 | 21.81 |
EV/FCF Ratio | 88.68 | 85.84 | 24.39 | 33.98 | - | 36.00 |
Debt / Equity Ratio | 0.61 | 0.61 | 0.76 | 0.86 | 0.40 | 0.05 |
Debt / EBITDA Ratio | 2.11 | 2.11 | 2.44 | 4.13 | 1.66 | 0.19 |
Debt / FCF Ratio | 9.78 | 9.78 | 2.72 | 7.79 | - | 0.36 |
Net Debt / Equity Ratio | 0.59 | 0.59 | 0.70 | 0.45 | 0.36 | -0.06 |
Net Debt / EBITDA Ratio | 2.05 | 2.05 | 2.26 | 2.18 | 1.53 | -0.25 |
Net Debt / FCF Ratio | 9.50 | 9.50 | 2.50 | 4.04 | -1.47 | -0.46 |
Asset Turnover | 0.43 | 0.43 | 0.41 | 0.37 | 0.56 | 0.65 |
Inventory Turnover | 2.06 | 2.06 | 2.80 | 2.47 | 2.90 | 2.49 |
Quick Ratio | 0.36 | 0.36 | 0.56 | 0.75 | 1.22 | 1.99 |
Current Ratio | 0.74 | 0.74 | 0.89 | 0.91 | 1.73 | 3.14 |
Return on Equity (ROE) | 18.07% | 18.07% | 11.54% | 14.59% | 18.12% | 23.29% |
Return on Assets (ROA) | 7.30% | 7.30% | 6.24% | 5.77% | 8.87% | 12.92% |
Return on Invested Capital (ROIC) | 14.01% | 14.33% | 10.55% | 11.84% | 16.19% | 23.95% |
Return on Capital Employed (ROCE) | 15.90% | 15.90% | 12.40% | 11.00% | 13.10% | 20.50% |
Earnings Yield | 3.24% | 3.45% | 1.82% | 3.42% | 4.91% | 4.34% |
FCF Yield | 1.26% | 1.34% | 4.71% | 3.11% | -7.07% | 2.75% |
Dividend Yield | 0.52% | 0.56% | 0.52% | - | 1.30% | 0.89% |
Payout Ratio | - | - | 28.44% | - | 26.14% | 20.10% |
Buyback Yield / Dilution | -0.43% | -0.43% | -0.09% | -0.03% | -0.19% | -0.02% |
Total Shareholder Return | 0.08% | 0.13% | 0.43% | -0.03% | 1.11% | 0.87% |